MDWD Earnings Date: Nov 19, 2026 (Estimated) — MediWound Ltd.
NASDAQ · Healthcare · Biotechnology
Updated
When is MDWD's next earnings date?
MediWound Ltd. (MDWD) is expected to report Q3 2026 earnings on Thursday, November 19, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.71 on revenue of $6.7M.
How did MDWD do in its last earnings report?
In its most recent report on Aug 13, 2026 (Q2 2026), MediWound Ltd. posted EPS of -$0.77 versus the -$0.76 estimate, a miss of 0.0%. Revenue was $3.1M against a $2.6M estimate. The stock's 1-day post-earnings move was -2.7%.
How much does MDWD stock move after earnings?
MDWD beat EPS estimates in 4 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 4.5% (up or down) in the day after earnings.
About MediWound Ltd.
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 | Q2 2026 | -0.76 | -0.77 | +0.00% | $3.1M | ❌ Miss | -2.73% | -2.30% | -5.75% |
| 2026-05-27 | Q1 2026 | -0.66 | -0.23 | +65.15% | $1.5M | ✅ Beat | -14.09% | -17.51% | -12.53% |
| 2026-03-05 | Q4 2025 | -0.63 | -0.56 | +11.11% | $1.9M | ✅ Beat | -0.85% | -2.16% | -4.49% |
| 2025-11-20 | Q3 2025 | -0.82 | -0.24 | +70.73% | $5.4M | ✅ Beat | -5.60% | +0.73% | +5.10% |
| 2025-08-14 | Q2 2025 | -0.56 | -1.23 | -119.64% | $5.7M | ❌ Miss | -0.96% | -6.99% | -4.85% |
| 2025-03-19 | Q4 2024 | -0.61 | -0.36 | +40.98% | $5.8M | ✅ Beat | -5.14% | -13.54% | -15.46% |
| 2024-11-26 | Q3 2024 | -0.44 | -0.98 | -122.73% | $4.4M | ❌ Miss | -2.48% | +6.29% | +2.89% |
| 2024-08-14 | Q2 2024 | -0.44 | -0.68 | -54.55% | $5.1M | ❌ Miss | -4.06% | +3.51% | -3.29% |
Showing last 8 quarters.